Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil J Freireich

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 20, 2012
The Society of Hematologic Oncology (SOHO): moving forward in the battle against hematologic malignanciesEmil J Freireich
Transfusion Medicine Reviews|June 3, 2011
Leukocyte transfusion and the development of the continuous-flow blood cell separatorEmil J Freireich
Transfusion Medicine Reviews|March 5, 2011
Origins of platelet transfusion therapyEmil J Freireich
Nature Clinical Practice. Oncology|February 8, 2006
The investigational new drug application--who benefits?Emil J Freireich
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Min Chiu Li: a perspective in cancer therapyEmil J Freireich
Clinical Advances in Hematology & Oncology : H&O|February 6, 2009
Rethinking the randomized clinical trial: the 21st century application of Freireich's laws. [An interview with Emil J Freireich by H&O]Emil J Freireich
BMJ (Clinical Research Ed.)|September 8, 2007
Should terminally ill patients have the right to take drugs that pass phase I testing? YesEmil J Freireich
Clinical Lymphoma, Myeloma & Leukemia|November 20, 2012
The history of leukemia therapy--a personal journeyEmil J Freireich
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
The role of investigational therapy in management of patients with advanced metastatic malignancyEmil J Freireich, Razelle Kurzrock
Blood|April 5, 2011
Twenty-five years of peripheral blood stem cell transplantationMartin Körbling, Emil J Freireich
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Clinical Lymphoma, Myeloma & Leukemia|November 20, 2012
The Society of Hematologic Oncology (SOHO): moving forward in the battle against hematologic malignanciesEmil J Freireich
Transfusion Medicine Reviews|June 3, 2011
Leukocyte transfusion and the development of the continuous-flow blood cell separatorEmil J Freireich
Transfusion Medicine Reviews|March 5, 2011
Origins of platelet transfusion therapyEmil J Freireich
Nature Clinical Practice. Oncology|February 8, 2006
The investigational new drug application--who benefits?Emil J Freireich
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Min Chiu Li: a perspective in cancer therapyEmil J Freireich
Clinical Advances in Hematology & Oncology : H&O|February 6, 2009
Rethinking the randomized clinical trial: the 21st century application of Freireich's laws. [An interview with Emil J Freireich by H&O]Emil J Freireich
BMJ (Clinical Research Ed.)|September 8, 2007
Should terminally ill patients have the right to take drugs that pass phase I testing? YesEmil J Freireich
Clinical Lymphoma, Myeloma & Leukemia|November 20, 2012
The history of leukemia therapy--a personal journeyEmil J Freireich
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
The role of investigational therapy in management of patients with advanced metastatic malignancyEmil J Freireich, Razelle Kurzrock
Blood|April 5, 2011
Twenty-five years of peripheral blood stem cell transplantationMartin Körbling, Emil J Freireich
Pageof 6